Latest DRC News

- Details
A new combination drug therapy is showing extraordinary promise in the bout against obesity, helping patients lose an average of 20 percent of their body weight in a major clinical trial.

- Details
Nine UAB faculty members elevated to Distinguished and University professorships

- Details
UAB Comprehensive Diabetes Center (UCDC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 85th Scientific Sessions, June 20-23, at the McCormick Place Convention Center in Chicago.

- Details
Ananda Basu, MBBS, MD, FRCP, M.D., has been selected as the director of the UAB Diabetes Research Center. His primary appointment will remain in the Heersink School of Medicine as the S. Richardson Hill, Jr. Endowed Professor of Endocrinology and director of the UAB Diabetes Technology Program. He will have a secondary appointment in the Department of Nutrition Sciences.

- Details
Weight loss medications have dramatically transformed obesity treatment, but there's a surprising trend emerging: many patients who find success on these drugs are stopping them. Why? And what happens next?

- Details
W. Timothy Garvey, M.D., a professor at the University of Alabama at Birmingham, was awarded the Gerald Reaven Distinguished Leader in Insulin Resistance Award by the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease. Garvey, known for developing Cardiometabolic Disease Staging, helps clinicians assess risk for Type 2 diabetes and cardiovascular disease, guiding treatment and weight loss therapy decisions.

- Details
W. Timothy Garvey, M.D., a professor at the University of Alabama at Birmingham, recently contributed to a groundbreaking global commission that called for a major overhaul of obesity diagnoses, recommending a shift away from relying solely on body mass index, or BMI, to more accurately define obesity as a disease.

- Details
W. Timothy Garvey, M.D., FACE, MABOM, Charles E. Butterworth, Jr., Professor of Medicine and University Professor in the Department of Nutrition Sciences at the University of Alabama at Birmingham, was given the Gerald Reaven Distinguished Leader in Insulin Resistance Award by the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC).

- Details
New research from the University of Alabama at Birmingham, published in the Journal of Clinical Endocrinology & Metabolism, shows that adults with Type 2 diabetes who follow a low-carbohydrate diet might experience improvements in their beta-cell function, potentially helping them manage their condition more effectively and potentially reduce or eliminate the need for medication.

- Details
While diabetes patients are categorized into two groups, either Type 1 or Type 2, no two patients are the same. The simple categorization often does not portray the disease and its many presentations, especially within different populations. For this reason, diabetes researchers and clinicians have emphasized the importance of growing the understanding of diabetes subtypes.